Late postnatal steroid treatment using oral betamethasone can help to close ductus arteriosus in extremely preterm infants who cannot be weaned from ventilation
2025

Oral Betamethasone Helps Close Ductus Arteriosus in Preterm Infants

Sample size: 51 publication 10 minutes Evidence: moderate

Author Information

Author(s): Remy Aude, Vincent Marine, Pastor-Diez Blandine, Picaud Jean-Charles

Primary Institution: Hospices Civils de Lyon

Hypothesis

Can late postnatal steroid treatment using oral betamethasone help close ductus arteriosus in extremely preterm infants who cannot be weaned from ventilation?

Conclusion

Oral betamethasone treatment can help wean invasive ventilation and is associated with ductus arteriosus closure in extremely preterm infants.

Supporting Evidence

  • 94.1% of infants were on invasive ventilation before treatment.
  • 91.7% of infants were extubated after betamethasone treatment.
  • 98.0% of infants had a closed or non-haemodynamically significant ductus arteriosus after treatment.

Takeaway

Giving a medicine called betamethasone to very tiny babies can help them breathe better and close a heart problem called ductus arteriosus.

Methodology

This was a retrospective, single-centre study evaluating the impact of oral betamethasone on ductus arteriosus closure in extremely preterm infants.

Potential Biases

The study may have biases related to its retrospective design and the specific treatment protocols used.

Limitations

The study's single-centre nature limited the number of eligible infants and may affect the generalizability of the results.

Participant Demographics

Infants were extremely preterm (GA < 29 weeks) with a median gestational age of 25.7 weeks and a birth weight of 720 g.

Statistical Information

P-Value

0.015

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s00431-024-05840-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication